A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure ; volume:17 ; number:1 ; day:17 ; month:1 ; year:2017 ; pages:1-5 ; date:12.2017
BMC infectious diseases ; 17, Heft 1 (17.1.2017), 1-5, 12.2017
- Keyword
-
Infektion
Infektiologie
- Creator
-
Eichenberger, Anna
- Contributor
-
Buechi, Annina E.
Neumayr, Andreas
Hatz, Chistroph
Rauch, Andri
Huguenot, Marc
Diamantis-Karamitopoulou, Eva
Staehelin, Cornelia
SpringerLink (Online service)
- DOI
-
10.1186/s12879-017-2192-4
- URN
-
urn:nbn:de:1111-201702137185
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eichenberger, Anna
- Buechi, Annina E.
- Neumayr, Andreas
- Hatz, Chistroph
- Rauch, Andri
- Huguenot, Marc
- Diamantis-Karamitopoulou, Eva
- Staehelin, Cornelia
- SpringerLink (Online service)
Other Objects (12)
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
Visceral leishmaniasis complicated with hemophagocytic lymphohistiocytosis and resistant to amphotericin B: a case report
Mediastinal Lymphadenopathy in Visceral Leishmaniasis
Acute liver failure due to visceral leishmaniasis in Barcelona: a case report
Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
Pediatric visceral leishmaniasis in Tartous, Syria
Spontaneous remission of fully symptomatic visceral leishmaniasis
Comorbid infections induce progression of visceral leishmaniasis
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
Visceral leishmaniasis complicated with hemophagocytic lymphohistiocytosis and resistant to amphotericin B: a case report
Mediastinal Lymphadenopathy in Visceral Leishmaniasis
Acute liver failure due to visceral leishmaniasis in Barcelona: a case report
Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
Pediatric visceral leishmaniasis in Tartous, Syria
Spontaneous remission of fully symptomatic visceral leishmaniasis
Comorbid infections induce progression of visceral leishmaniasis
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
Visceral leishmaniasis complicated with hemophagocytic lymphohistiocytosis and resistant to amphotericin B: a case report
Mediastinal Lymphadenopathy in Visceral Leishmaniasis
Acute liver failure due to visceral leishmaniasis in Barcelona: a case report
Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
Pediatric visceral leishmaniasis in Tartous, Syria
Spontaneous remission of fully symptomatic visceral leishmaniasis